Barbara Schaeffler
About Barbara Schaeffler
Barbara Schaeffler’s Current Role at Zymeworks
Barbara Schaeffler serves as the Vice President of Clinical Development Operations at Zymeworks. In this role, she oversees the management and execution of clinical trial programs, ensuring they adhere to regulatory standards and are completed efficiently. Her work involves leading teams, coordinating with internal and external stakeholders, and contributing to the strategic planning of the company’s clinical development initiatives.
Barbara Schaeffler's Educational Background
Barbara Schaeffler holds an MBA and a bachelor's degree in Bacteriology from the University of California. Her academic background in business administration and the biological sciences provides a solid foundation for her extensive career in the biotechnology and biopharmaceutical sectors. This combination of education has enabled her to navigate both the scientific and managerial aspects of clinical development.
Barbara Schaeffler's Previous Roles and Industry Experience
Before joining Zymeworks, Barbara Schaeffler was the Vice President of Clinical Operations at Syndax Pharmaceuticals. With over 27 years in the biotechnology and biopharma industries, she has also held significant roles at organizations such as Lundbeck, Alder Biopharmaceuticals, Poniard Pharmaceuticals, Pathogenesis, Chiron, and PATH. Her experience encompasses leading departments and project teams through various phases of clinical trials, regulatory filings, and drug approvals.
Barbara Schaeffler's Expertise in Clinical Development and Operations
Barbara Schaeffler has substantial expertise in clinical development and operations, having led numerous departments and project teams in the biopharmaceutical sector. Her responsibilities have included the comprehensive management of clinical trials, from planning and execution to regulatory submission and approval. Her work at companies like Lundbeck and Alder Biopharmaceuticals highlights her capability in guiding projects through to successful completion.